Clinical Trials Directory

Trials / Completed

CompletedNCT03543956

Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of Exposition

Status
Completed
Phase
Study type
Observational
Enrollment
226 (actual)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Systemic Sclerosis (SSc) is an inflammatory chronic disease that can lead to structural damage and handicap. The SSc physiopathology is multifactorial, including genetic and environmental risk factors. The identification of environmental factors implication is crucial to understand the SSc mechanism, and improves the diagnosis and the treatment of the disease.

Detailed description

Studies show that the risk associated with high cumulative exposure to silica and organic solvents appears to be strongly increased in SSc. Moreover, exposure to silica is associated with a specific type of SSc phenotype with a worse prognosis. However, the type, intensity and probability of these expositions are unknown. The aim of the study is to precisely determine type, intensity and probability of toxic substances exposition in Systemic Sclerosis patients through an auto-questionnaire and integration of these data in a computer matrix.

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuestionnaireQuestionnaire

Timeline

Start date
2018-06-04
Primary completion
2019-06-27
Completion
2019-06-27
First posted
2018-06-01
Last updated
2019-09-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03543956. Inclusion in this directory is not an endorsement.